Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,014.60 -230.64 -1.74%
Hang Seng 20,430.20 -556.73 -2.65%
S&P/ASX 200 4,758.40 -102.98 -2.12%
  • Exchange: -
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Health Care Supplies

BioMimetic Therapeutics Inc

BMTI:US

Acquired

Company Profile for BioMimetic Therapeutics Inc (BMTI)

BioMimetic Therapeutics, Inc. develops and markets drug-device products for the repair of orthopedic injuries to bond, cartilage, ligaments, and tendons. The Company combines protein therapeutics with tissue scaffolds to stimulate tissue healing and regeneration.

Contact Information

BioMimetic Therapeutics Inc

389 Nichol Mill Lane
Franklin, TN 37067
United States
Phone: 1-615-844-1280
Fax: 1-615-844-1281

Key Executives for BioMimetic Therapeutics Inc (BMTI)

Samuel E Lynch "Sam"President/CEO/FounderLawrence E Bullock "Larry"CFO/Secretary
Russ PaganoVP:Regulatory & Clinical

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil